Gainers & Losers
Tue Dec 09 2025 09:55:52- Eternal share price
- ₹291.852.31%
- Titan Company share price
- ₹3,846.702.17%
- Adani Ports and Special Ec...
- ₹1,495.701.07%
- Bharat Electronics share price
- ₹389.950.89%
- State Bank of India share price
- ₹960.050.41%
Active Stocks
Tue Dec 09 2025 10:28:53- Suzlon Energy share price
- ₹52.571.51%
- Yes Bank share price
- ₹22.020.64%
- Federal Bank share price
- ₹260.951.38%
- Adani Power share price
- ₹142.002.12%
- Canara Bank share price
- ₹146.052.24%
Business News/Market/Market Stats/Cohance Lifesciences share price/ Cohance Lifesciences Profit Loss Annual
Cohance Lifesciences Profit & Loss Annual
535.50 +4.80 (0.90%)Updated : 09 Dec 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 899.76 | 700.00 | 821.52 | 779.69 |
| Other Net | -0.65 | 6.35 | 3.40 | 75.79 |
| Diluted Weighted Average Shares | 25.58 | 25.46 | 25.46 | 25.46 |
| Gain( Loss)on Saleof Assets | -0.11 | -0.14 | -0.01 | -0.20 |
| Depreciation/ Amortization | 77.49 | 54.50 | 47.73 | 39.10 |
| Operating Income | 297.82 | 351.35 | 518.81 | 540.53 |
| Net Income | 267.87 | 300.28 | 411.29 | 453.80 |
| Income Availableto Com Excl Extra Ord | 267.87 | 300.28 | 411.29 | 453.80 |
| Other Operating Expenses Total | 104.72 | 50.00 | 61.91 | 51.84 |
| Net Income Before Taxes | 343.92 | 405.67 | 559.73 | 667.59 |
| Minority Interest | 3.10 | - | - | - |
| Net Income After Taxes | 264.77 | 300.28 | 411.29 | 453.80 |
| Income Availableto Com Incl Extra Ord | 267.87 | 300.28 | 411.29 | 453.80 |
| Costof Revenue Total | 352.58 | 432.62 | 568.34 | 550.28 |
| Gross Profit | 845.00 | 618.73 | 771.99 | 769.94 |
| Interest Inc( Exp) Net- Non- Op Total | 46.86 | 48.10 | 37.53 | 51.47 |
| Unusual Expense( Income) | 30.26 | 3.22 | - | - |
| Diluted Net Income | 267.87 | 300.28 | 411.29 | 453.80 |
| Provisionfor Income Taxes | 79.15 | 105.39 | 148.44 | 213.79 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 267.87 | 300.28 | 411.29 | 453.80 |
| Total Revenue | 1,197.58 | 1,051.35 | 1,340.33 | 1,320.22 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 1,197.58 | 1,051.35 | 1,340.33 | 1,320.22 |
| Selling/ General/ Admin Expenses Total | 334.71 | 159.66 | 134.95 | 128.12 |
| Diluted Normalized EPS | 11.38 | 11.89 | 16.16 | 17.83 |
| Diluted EPS Excluding Extra Ord Items | 10.47 | 11.80 | 16.16 | 17.83 |
| Total Adjustmentsto Net Income | - | 0.00 | - | 0.00 |
| DPS- Common Stock Primary Issue | - | - | 1.00 | 2.00 |
| Research Development | - | - | 8.59 | 10.35 |
*All figures in crores except per share values
Cohance Lifesciences Quick Links
Cohance Lifesciences Dividend Cohance Lifesciences Bonus Cohance Lifesciences News Cohance Lifesciences AGM Cohance Lifesciences Rights Cohance Lifesciences Splits Cohance Lifesciences Board Meetings Cohance Lifesciences Key Metrics Cohance Lifesciences Shareholdings Cohance Lifesciences Balance Sheet Cohance Lifesciences Cashflow Cohance Lifesciences Q1 Results Cohance Lifesciences Q2 Results Cohance Lifesciences Q3 Results Cohance Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
291.85+6.60(2.31%)
3,846.70+81.70(2.17%)
1,495.70+15.90(1.07%)
2,790.70-135.10 (-4.62%)
1,559.80-31.95 (-2.01%)